• Scientific Publications

     

    Articles

    1. Craven DE, Palladino R, McQuillen DP. Healthcare-associated pneumonia in adults: management principles to improve outcomes. Infect Dis Clin North Am 2004;18(4):939-962.

       
    2. Graham CS, Curry M, HE Q, Afdal N, Nunes D, Fleming C, Horsburgh R, Craven DE, Sherman KE, Koziel MJ. Comparison of hepatitis C virus (HCV)-specific intra-hepatic CD4+ T cells in patients with human immunodeficiency virus (HIV) and HCV versus HCV infection alone. Hepatology 2004;40(1):125-132.

       
    3. Fleming CA, Christiansen D, Nunes D, Heeren T, Thornton D, Horsburgh CR Jr, Koziel MJ, Graham C, Craven DE. Health-related quality of life of patients with HIV disease: impact of hepatitis C co-infection. Clin Infect Dis 2004;38(4):572-578.

       
    4. Craven DE. Blood cultures for community-acquired pneumonia: piecing together a mosaic for doing less. Am J Resp Crit Care Med 2004;169(3):327-328.

       
    5. Hanna GJ, Balaguera HU, Freedberg KA, Werner BG, Steger Craven KA, Craven DE, D'Aquila RT. Drug-selected resistance mutations and non-B subtypes in antiretroviral-naive adults with established human immunodeficiency virus infection. J Infect Dis 2003;188(7):986-991.

       
    6. Weiss SC, Moschella SL, Kwan T, Craven DE. Cutaneous mucormycosis secondary to acquired reactive perforating collagenosis. Cutis 2003;72(2):119-123.

       
    7. Craven DE. Progress in the battle against nosocomial legionnaires disease: shedding light on shades of gray. Infect Control Hosp Epidemiol 2003; 24(8):560-562.

       
    8. Ooi WW, Srinivasan J. Leprosy and the peripheral nervous system. Muscle and Nerve 2004;30(4):393-409.

       
    9. Gawoski JM, Ooi WW. Dengue fever mimicking plasma cell leukemia. Arch Pathol Lab Med 2003;127:1026-1027.

       
    10. Hugonnet S, Harbarth S, Sax H, Duncan RA, Pittet D. Nursing resources: A major determinant of nosocomial infection? Curr Opin Infect Dis 2004; 17:329-333.

       
    11. Shapiro DS. Surge capacity for response to bioterrorism in hospital clinical microbiology laboratories. J Clin Micro 2003;41(12):5372-5376.

       
    12. Klempner MS, Shapiro DS. Crossing the species barrier - one small step to man, one giant leap to mankind. N Engl J Med 2004;352:1171-1172. 

       
    13. Alvarez M, Tran JH, Chow N, Jacoby GA. Epidemiology of conjugative plasmid-mediated AmpC β-lactamases in the United States. Antimicrob Agents Chemother 2004;48:533-537.

       
    14. Wang M, Sahm DF, Jacoby GA, Hooper DC. Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob Agents Chemother 2004;48: 1295-1299.

       
    15. Wang M, Sahm DF, Jacoby GA, Zhang Y, Hooper DC. Activities of newer quinolones against Escherichia coli and Klebsiella pneumoniae containing the plasmid-mediated quinolone resistance determinant qnr. Antimicrob Agents Chemother 2004;48:1400-1401.

       
    16. Jacoby G, Mills D, Chow N. Role of β-lactamases and porins in resistance to ertapenem and other β-lactams in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004;48:3203-3206.

       
    17. Jacoby GA, Munoz-Price LS. The new beta-lactamases. N Engl J Med 2005 Jan 27;352(4):380-91.

       
    18. Craven DE. Prevention and pathogenesis of ventilator-associated pneumonia: Sowing seeds of change. Chest, 2006, 130:251-260.

       
    19. Craven DE, Duncan RA. Preventing Ventilator-associated pneumonia: Tiptoeing through a minefield. Am J Resp & Crit Care Med, 2006; 173:1297-98 (Editorial).

       
    20. Craven DE, Shapiro DS. Staphylococcus aureus:: Times, they are changin'. Clin Infect Disease, 2006: 42:179-80. (Editorial)

       
    21. Gorman S, Magiorakos A, Craven D, Pulmonary Fusariosis Successfully Treated with Voriconazole, Southern Medical Journal, 2006, 173:1297-98

       
    22. Solages A. Vita JA, Thornton DJ, Murray J, Heeren T, Craven DE, Horsburgh RC, Jr. Endothelial function in HIV-infected persons, Clin Infect Dis; 2006 42:1325-32.

       
    23. Craven DE, What is healthcare-associated pneumonia and how should it be managed? Current Opinion, 2006, 19l: 153-160.

       
    24. Craven DE. 2005 IDSA/ATS hospital-acquired pneumonia Guidelines: New principles for improving management, Johns Hopkins Advanced Studies in Medicine, 2006; 6: S541-S548.

       
    25. Benou C, Rael E, Welch H, Craven D, Pasteurella multocida abscess and fasciitis presenting as chronic leg edema, Infections in Medicine, 2006; 23: 439-441.

       
    26. Ooi W, Gallagher A RN, Chen L, Immunity to hepatitis A and hepatitis B in Indian and Chinese immigrants seen in a travel clinic in Massachusetts, United States. Journal of Travel Medicine, 2006; 13: 212-218

       
    27. Gorman S, Duncan R, Dellaripa P. Recognizing Strongyloides hyperinfection. Infections in Medicine. 2006; 23:480-484.

       
    28. American Thoracic Society & Infectious Diseases Society of America (Niederman MS and Craven DE, Co-Chairs). Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia. Am J Respir Crit Care Med, 2005;171:388-416.

       
    29. Akselband Y., Cabral C., Shapiro D.S., and McGrath P. Rapid mycobacteria drug susceptibility testing using gel microdrop (GMD) growth assay and flow cytometry. Journal of Microbiological Methods, 62:181-197 (2005).

    Abstracts

    1. Clark RP, Tolo EF, Harris GS, Zimmerman SK, McQuillen DP. Necrotizing fasciitis due to Mycobacterium kansasii in a patient with rheumatoid arthritis on infliximab. Abstracts of the 44th Annual Meeting of the Infectious Diseases Society of America, Toronto, Ontario, Canada, 2006.

       
    2. Small LN, Duncan RA, Cook SC, McDermott L, Baez-Giangreco C, Hansjosten K, Snydman D. Challenging a Gold Standard of Molecular Epidemiology: A Methicillin-Resistant Staphylococcus aureus (MRSA) Outbreak Investigation. Abstracts of the 44th Annual Meeting of the Infectious Diseases Society of America, Toronto, Ontario, Canada, 2006. Abstract 391.

       
    3. Duncan, RA, Willey S, Eyre-Kelly J. A comprehensive Infection Control Program: Benefits of Adding an Infection Control Practitioner. Abstracts of the 16th Conference for the Society for Healthcare Epidemiology of America, Chicago, IL, 2006.

       
    4. Wener, KM, Gold HS, Baldini LM, Wright SB. Getting it right the first time: predictors of Methicillin-resistance in Staphylococcus aureus (MRSA) skin and soft tissue infections in emergency department patients. Abstract of the 16th Conference for the Society for Healthcare Epidemiology of America, Chicago, IL, 2006.

       
    5. Wener, KM, Gold HS, Wright SB, Carmeli Y. Collateral damage by antibiotics: beta-lactamase inhibitors and quinolones may have greater effect than cephalosporins on the risk of isolation of ESBL producing Klebsiella species among hospitalized patients. Abstract of the 16th Conference for the Society for Healthcare Epidemiology of America, Chicago, IL, 2006.

       
    6. Wener, KM, Gold HS, Wong M, Venkataraman L, Mayer KH, Cohen DE, Wright SB. High prevalence of methicillin-resistant S. Aureus (MRSA) colonization in an urban outpatient population. Abstract of the 44th Conference for the Infectious Disease Society of America, Toronto, ON, 2006.

       
    7. Tilahun Y., Brecher S., Gillespie W., Shapiro D., and Oliveira K. Rapid identification of vancomycin-resistant enterococci directly from positive blood culture bottles using vanA/B EVIGENET. Abstract C-036. The 107th General Meeting of the American Society for Microbiology, (2007).

       
    8. Cook S., Campbell K., Geannaris S., and Shapiro D. Evaluation of the MGB ALERTT HSV1/2 typing and non-typing ASRs. 22nd Annual Clinical Virology Symposium (2006).

       
    9. Oliveira K., Shapiro D., Gillespie W., Rasmussen A., and Stender H. Rapid Identification of S. Aureus and Differentiation Between MRSA and MSSA from Blood Culture Bottles using S. aureus/CNS PNA FISH and MRSA EVIGENE. Abstract C-309. The 105th General Meeting of the American Society for Microbiology, (2005).

       
    10. DeHaan P., Houck H., Croy T., Shapiro D., Oliveira K., and Fiandaca M.J. Evaluation of the S. aureus PNA FISHT assay on a fully automated instrument platform, the Ventana DiscoveryT, for rapid analysis of positive blood cultures. Abstract C-88. The 105th General Meeting of the American Society for Microbiology, (2005). 

     

    ProMED Updates

    1. Cooke F. and Shapiro D.S. ProMED update. International Journal of Infectious Diseases, 11(3):189-190 (2007).
    2. Cooke F. and Shapiro D.S. ProMED update. International Journal of Infectious Diseases, 11(2):91-92 (2007).
    3. Cooke F. and Shapiro D.S. ProMED update. International Journal of Infectious Diseases, 11(1):1-2 (2007).
    4. Cooke F. and Shapiro D.S. ProMED update. International Journal of Infectious Diseases, 10(6):415-416 (2006).
    5. Cooke F. and Shapiro D.S. ProMED update. International Journal of Infectious Diseases, 10(5):341-342 (2006).
    6. Cooke F. and Shapiro D.S. ProMED update. International Journal of Infectious Diseases, 10(4):269-271 (2006).
    7. Cooke F. and Shapiro D.S. ProMED update. International Journal of Infectious Diseases, 10(3):191-192 (2006).
    8. Cooke F. and Shapiro D.S. ProMED update. International Journal of Infectious Diseases, 10(2):91-92 (2006).
    9. Cooke F. and Shapiro D.S. ProMED update. International Journal of Infectious Diseases, 10(1):1-2 (2006). 

    Chapters

    1. Craven DE, Steger Craven KA, De Rosa FG. Healthcare-Associated Infections in Adults Infected with Human Immunodeficiency Virus. In: Mayhall CG, Ed., Hospital Epidemiology and Infection Control, 3rd Ed. Philadelphia, PA: Lippincott, Williams and Wilkins 2004;57:945-968.

       
    2. Duncan RA, Lawrence KR. Antimicrobial stewardship. In: Lautenbach E, Woeltje K, Eds., Practical Handbook for Hospital Epidemiologists, 2nd Ed. Thorofare, NJ: SLACK, Inc. 2004;18:199-209.

       
    3. Shapiro DS. Infections acquired from animals other than pets. In: Cohen J, Powderly B, Eds., Infectious Diseases, 2nd Ed. Elsevier Health Sciences 2004;92:977-985.

       
    4. Shapiro D.S. Zoonoses. Chapter 73, pages 697-706. In: Schaechter's Mechanisms of Microbial Disease, fourth edition, edited by N. C. Engleberg, V. DiRita, T. Dermody, Lippincott Williams & Wilkins (2006). 

    Books

    Read RC, Craven DE. Respiratory Tract Infection, 2nd Ed. Health Press, 2003.

    Gilligan P, Smiley ML, and Shapiro D. Cases in Medical Microbiology and Infectious Diseases, 3rd ed. American Society for Microbiology Press, 2003

     

    National Guideline Documents

    Shapiro D.S., Sharp S.E. Sentinel laboratory guidelines for suspected agents of bioterrorism. Clinical laboratory bioterrorism readiness plan. American Society for Microbiology. (revised, 2006).

    Shapiro D.S., Weissfeld A.S. Sentinel laboratory guidelines for suspected agents of bioterrorism. Botulinum toxin. American Society for Microbiology. (2003).

    Snyder J., Shapiro D.S., Gilchrist M., Weyant R., Popovic T., Ezzell J, Morse S. Basic diagnostic testing protocols for level A laboratories for the presumptive identification of Bacillus anthracis. Centers for Disease Control and Prevention, American Society for Microbiology, Association of Public Health Laboratories. (2002). 





     

  • Make an Appointment

    (781) 744-8000